Synchronous primary breast invasive carcinoma and breast metastasis from high-grade serous ovarian carcinoma: a case report and literature review - Report - MDSpire
Advertisement
Synchronous primary breast invasive carcinoma and breast metastasis from high-grade serous ovarian carcinoma: a case report and literature review
Concurrent Invasive Breast Carcinoma and Metastatic High-Grade Serous Ovarian Carcinoma
Overview
This report presents a rare case of synchronous invasive breast carcinoma and metastatic high-grade serous ovarian carcinoma. The patient underwent a series of treatments, achieving a partial response and no evidence of disease progression at the last follow-up.
Background
Incorporate statistics or references regarding the rarity of breast metastasis from ovarian carcinoma.
Data Highlights
No numerical data available.
Key Findings
The patient was diagnosed with FIGO stage IVB high-grade serous ovarian carcinoma with synchronous primary breast carcinoma.
Pathological examination revealed two distinct adenocarcinoma components in the breast: primary invasive carcinoma and metastatic Müllerian carcinoma.
Immunohistochemical profiling was essential for distinguishing between the two carcinoma types.
The patient received neoadjuvant chemotherapy and achieved a partial response prior to surgical intervention.
Molecular testing indicated a pathogenic BRCA mutation, supporting the use of PARP inhibitors in maintenance therapy.
Clinical Implications
Healthcare professionals should be aware of the potential for breast metastasis from ovarian carcinoma, which can mimic primary breast cancer. A thorough immunohistochemical panel is critical for accurate diagnosis, guiding appropriate treatment strategies. Multidisciplinary approaches are recommended for complex cases involving synchronous malignancies.
Conclusion
This case highlights the diagnostic challenges and treatment complexities associated with concurrent breast and ovarian carcinomas. Careful histopathological and immunohistochemical evaluation is vital for optimal patient management.